Accellacare of Hickory

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Obesity3 trials
• Gout1 trial
• Psoriasis1 trial
• Psoriatic arthritis1 trial
• Type 2 diabetes1 trial

Phase

• Phase 33 trials
• Phase 21 trial
• Phase 41 trial

Status

• Active, not recruiting3 trials
• Completed1 trial
• Recruiting1 trial

Lead sponsor

• Amgen3 trials
• Hanmi Pharmaceutical Company Limited1 trial
• Takeda1 trial

Running trials

• Recruiting

  Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

  NCT07684235· Phase 3· Amgen· Source

• Active, not recruiting

  Study to Evaluate HM15275 in Obese or Overweight Subjects Without Diabetes Mellitus

  NCT07205900· Phase 2· Hanmi Pharmaceutical Company Limited· Source

• Active, not recruiting

  Evaluation of Maridebart Cafraglutide in Adult Participants Without Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight

  NCT06858839· Phase 3· Amgen· Source

• Active, not recruiting

  A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines

  NCT06671483· Phase 3· Takeda· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Obesity1 recruiting

Closed trials

• Completed

  A Trial to Investigate the Non-inferiority of Pegloticase Administered Every 4 Weeks (Q4W) With MTX Compared With Every 2 Weeks (Q2W) With MTX in Participants With Uncontrolled Refractory Gout

  NCT06229145· Phase 4· Amgen· Source